(Q45723125)

15 December 2017

Hepatic steatosis in patients with chronic hepatitis C virus infection. Another risk factor for hepatocellular carcinoma? (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

2

Raymond T Chung

1 reference

15 December 2017

Andrew X Zhu

1

1 reference

PubMed ID

12784328

15 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

15 December 2017

1 reference

15 December 2017

97

1 reference

15 December 2017

12

1 reference

15 December 2017

2948-2950

1 reference

Rising incidence of hepatocellular carcinoma in the United States

15 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11440

7 January 2021

Identifiers

DOI

10.1002/CNCR.11440

1 reference

release_wfafoyoqvbesdlsj764cwub4hm

15 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wfafoyoqvbesdlsj764cwub4hm

24 November 2022

mapped directly with Wikidata item

PubMed ID

12784328

1 reference

PubMed ID

12784328